Study |
N= |
Mortality |
Mortality |
Stroke |
Stroke |
Emergent cases |
Emergent cases |
|
|
ACP |
RCP |
ACP |
RCP |
ACP |
RCP |
Abdelgawad A, et al 2017 23
|
43 |
3 (16.7%) |
4
(16%) |
1 (5.6%) |
2 (8%) |
6 (33.3%) |
7 (28%) |
Apaydin AZ, et al. 2009 36
|
239 |
N/A |
N/A |
2/13
(10%) |
0 (0%) |
N/A |
N/A |
Apostolakis E, et. al 2008 24
|
48 |
3/23 (13%) |
4/25 (16%) |
1/23 (4.3%) |
1/25 (4%) |
N/A |
N/A |
Ganapathi AM, et al 2014 14
|
440 |
3 (3.8%) |
2
(2.5%) |
2 (2.5%) |
1 (1.3%) |
11 (13.8%) |
9
(11.3%) |
Ghoreishi M, et al. 2019 27
|
7353 |
N/A |
N/A |
434
(46%) |
184 (20%) |
N/A |
N/A |
Itagaki S, et al. 2019 28
|
7830 |
207 (6.1%) |
83
(4.4%) |
179 (5.3%) |
75 (4.0%) |
N/A |
N/A |
Leshnower BG, 2019 26
|
20 |
0 |
0 |
1(9%) |
1 (11%) |
N/A |
N/A |
Soliman S, et al. 2018 37
|
50 |
2 (8%) |
3 (12%) |
1 (4%) |
1 (4%) |
N/A |
N/A |
Stevens L, et al. 2009 38
|
195 |
N/A |
N/A |
5 (9%) |
0 (0%) |
N/A |
N/A |
Sundt TM III, et al. 2008 39
|
347 |
2 (4.4%) |
3
(9.4%) |
2 (5.4%) |
1 (7.1%) |
N/A |
N/A |
Sugiura T, et al. 2012 40
|
203 |
2 (2.1%) |
7
(6.4%) |
11 (12%) |
10 (9.2%) |
94 (100%) |
109
(100%) |
Tokuda Y, et al. 2014 29
|
4128 |
N/A |
N/A |
311
(11.2%) |
132 (9.7%) |
N/A |
N/A |
Usui A, et al. 2012 41
|
2792 |
3.5% |
2.6% |
6.8% |
3.1% |
N/A |
N/A |
Wiedemann D, et al. 2013 25
|
329 |
12 (13%) |
20
(16%) |
11 (12%) |
15 (12%) |
N/A |
N/A |
ACP: antegrade cerebral perfusion; RCP: retrograde cerebral perfusion. |
ACP: antegrade cerebral perfusion; RCP: retrograde cerebral perfusion. |
ACP: antegrade cerebral perfusion; RCP: retrograde cerebral perfusion. |
ACP: antegrade cerebral perfusion; RCP: retrograde cerebral perfusion. |
ACP: antegrade cerebral perfusion; RCP: retrograde cerebral perfusion. |
ACP: antegrade cerebral perfusion; RCP: retrograde cerebral perfusion. |
ACP: antegrade cerebral perfusion; RCP: retrograde cerebral perfusion. |
ACP: antegrade cerebral perfusion; RCP: retrograde cerebral
perfusion. |